These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparative effects of neurotensin, neurotensin(8-13) and [D-Tyr(11)]neurotensin applied into the ventral tegmental area on extracellular dopamine in the rat prefrontal cortex and nucleus accumbens. Sotty F; Brun P; Leonetti M; Steinberg R; Soubrié P; Renaud B; Suaud-Chagny MF Neuroscience; 2000; 98(3):485-92. PubMed ID: 10869842 [TBL] [Abstract][Full Text] [Related]
4. Neuromedin N decreases self-stimulation of the medial prefrontal cortex. Ferrer JM; Sabater R; Sáez JA Neuroreport; 1992 Nov; 3(11):1027-9. PubMed ID: 1482762 [TBL] [Abstract][Full Text] [Related]
5. Mediation by neurotensin-receptors of effects of neurotensin on self-stimulation of the medial prefrontal cortex. Fernández R; Sabater R; Sáez JA; Montes R; Alba F; Ferrer JM Br J Pharmacol; 1996 Sep; 119(2):299-302. PubMed ID: 8886412 [TBL] [Abstract][Full Text] [Related]
6. Central neurotensin receptor activation produces differential behavioral responses in Fischer and Lewis rats. Bauco P; Rompré PP Psychopharmacology (Berl); 2003 Jul; 168(3):253-61. PubMed ID: 12682711 [TBL] [Abstract][Full Text] [Related]
7. Opposite effects of mesencephalic microinjections of cholecystokinin octapeptide and neurotensin-(1-13) on brain stimulation reward. Rompré PP; Boye SM Eur J Pharmacol; 1993 Mar; 232(2-3):299-303. PubMed ID: 8467866 [TBL] [Abstract][Full Text] [Related]
8. Repeated ventral midbrain neurotensin injections sensitize to amphetamine-induced locomotion and ERK activation: A role for NMDA receptors. Voyer D; Lévesque D; Rompré PP Neuropharmacology; 2017 Jan; 112(Pt A):150-163. PubMed ID: 27267684 [TBL] [Abstract][Full Text] [Related]
9. Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats. Fredrickson P; Boules M; Yerbury S; Richelson E Eur J Pharmacol; 2003 Jan; 458(1-2):111-8. PubMed ID: 12498914 [TBL] [Abstract][Full Text] [Related]
10. Facilitation of brain stimulation reward by mesencephalic injections of neurotensin-(1-13). Rompré PP; Bauco P; Gratton A Eur J Pharmacol; 1992 Feb; 211(3):295-303. PubMed ID: 1319909 [TBL] [Abstract][Full Text] [Related]
11. Effects of neurotensin on midbrain dopamine neurons: are they mediated by formation of a neurotensin-dopamine complex? Shi WX; Bunney BS Synapse; 1991 Nov; 9(3):157-64. PubMed ID: 1776128 [TBL] [Abstract][Full Text] [Related]
12. Neurotensin participates in self-stimulation of the medial prefrontal cortex in the rat. Ferrer JM; Sabater R; Saez JA Eur J Pharmacol; 1993 Jan; 231(1):39-45. PubMed ID: 8444280 [TBL] [Abstract][Full Text] [Related]
13. Electrophysiological evidence for putative subtypes of neurotensin receptors in guinea-pig mesencephalic dopaminergic neurons. Nalivaiko E; Michaud JC; Soubrié P; Le Fur G Neuroscience; 1998 Oct; 86(3):799-811. PubMed ID: 9692718 [TBL] [Abstract][Full Text] [Related]
14. Peptidase inhibitors potentiate the effects of neurotensin and neuromedin N on self-stimulation of the medial prefrontal cortex. Fernández R; Alba F; Ferrer JM Neuroreport; 1996 Feb; 7(3):798-800. PubMed ID: 8733748 [TBL] [Abstract][Full Text] [Related]
15. Mesencephalic microinjections of neurotensin-(1-13) and its C-terminal fragment, neurotensin-(8-13), potentiate brain stimulation reward. Rompré PP; Gratton A Brain Res; 1993 Jul; 616(1-2):154-62. PubMed ID: 8358607 [TBL] [Abstract][Full Text] [Related]
16. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux. Prus AJ; Huang M; Li Z; Dai J; Meltzer HY Brain Res; 2007 Dec; 1184():354-64. PubMed ID: 17988654 [TBL] [Abstract][Full Text] [Related]
17. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders. Petkova-Kirova P; Rakovska A; Zaekova G; Ballini C; Corte LD; Radomirov R; Vágvölgyi A Neurochem Int; 2008 Dec; 53(6-8):355-61. PubMed ID: 18835308 [TBL] [Abstract][Full Text] [Related]
18. Effects of lesions in the medial prefrontal cortex on the activity of midbrain dopamine neurons. Shim SS; Bunney BS; Shi WX Neuropsychopharmacology; 1996 Nov; 15(5):437-41. PubMed ID: 8914116 [TBL] [Abstract][Full Text] [Related]
19. Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens. Laitinen K; Crawley JN; Mefford IN; De Witte P Brain Res; 1990 Jul; 523(2):342-6. PubMed ID: 1698106 [TBL] [Abstract][Full Text] [Related]
20. Effects of excitotoxic lesions of the medial prefrontal cortex on density of high affinity [125I-Tyr3]neurotensin binding sites within the ventral midbrain and striatum. Radja F; Bauco P; Rompré PP Eur J Pharmacol; 2006 Jun; 539(3):158-63. PubMed ID: 16714012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]